Top Markets
Coin of the day
OmniAb, Inc. OmniAb, Inc.

OmniAb, Inc.

OABI
Classifica tra le azioni #11871
OmniAb, Inc. is an American biotechnology firm focused on pioneering... OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.
Prezzo delle azioni
$4.48
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$649.33M
Variazione (1 giorno)
-2.84%
Variazione (1 anno)
179.94%
Paese
US
Scambia OmniAb, Inc. (OABI)

Categoria

Storico del prezzo dell'azione per OmniAb, Inc. (OABI)
Prezzo di chiusura più alto: $3.89 il 2026-08-01

Prezzo di chiusura più basso: $9.76 il 2021-09-01
Storico del prezzo dell'azione di OmniAb, Inc. dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 1.00%
2025 -47.69%
2024 -30.70%
2023 49.25%
2022 -63.59%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH